Slide 1: Q4 FY12 Shareholder Conference Call
July 16, 2012 © 2012. All rights reserved. Q4 FY12 Shareholder Conference Call
Slide 2: Safe Harbor Statement
Safe Harbor Statement Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Any statements set forth in this presentation that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially
Slide 3: Agenda
Agenda • Q4 Overview • Q4 and FY 2012 Financial Detail • Ranor Challenges and Responses • Product Diversification • FY13 Outlook
Slide 4: Q4 Income Statement
Consolidated Income Statement ($ in Millions except Shares & EPS) Q4 2012 Q4 2011 FY 2012 FY 2011 Revenues $6.1 $8.1 $33.3 $32.3 Gross Margin 0.03% 26.7% 15.3% 30.7% Operating Income (loss) $(2.8) $0.4 $(3.4) $4.7 Net Income (loss) $(1.3) $0.2 $(2.1) $2.7 EPS - Diluted $(0.07) $0.00 $(0.13) $0.12 Q4
Slide 5: Revenue Distribution
Revenue Distribution Solar Production from Q2 recognized in Q3 • Solar equipment revenues decreased from ~50% to 20% of total business • WCMC division revenue was $4.6-million from Solar Customer(s) from 9-months of volume production in fiscal • Ranor division missed its internal revenue plan by ~$5
Slide 6: Q4 Income Statement
Consolidated Income Statement ($ in Millions except Shares & EPS) Q4 2012 Q4 2011 FY 2012 FY 2011 Revenues $6.1 $8.1 $33.3 $32.3 Gross Profit $0.002 $2.2 $5.1 $9.9 Gross Margin 0.03% 26.7% 15.3% 30.7% Operating Expenses $2.8 $1.8 $8.5 $5.2 Operating (Loss) Income $(2.8) $0.4 $(3.4) $4.7 Operating Ma
Slide 7: Balance Sheet Highlights
($ in Millions) March 31, 2012 March 31, 2011 Cash 2.8 7.5 Current Assets 16.3 17.7 Total Assets 24.0 22.9 Current Liabilities 6.1 4.1 Total Liabilities 11.9 9.3 Total Stockholders’ Equity 12.2 13.9 Long-Term Debt March 31, 2012 Term Note 571,429 Series A & B Bonds 5,627,082 Capex Debt/Capital Lease
Slide 8: Ranor Challenges and Transition
Ranor Challenges and Transition Moving the Ranor division from dominant single customer and repetitious “production environment” of the previous 5+ years to larger-scale prototypes which will evolve to volume products in Medical, Nuclear and Defense sectors Bob Francis was hired to lead Ranor throug
Slide 9: Product Solution Strategy
Product Solution Strategy • Historically the Company produced piece-part (highly competitive/less value-add to customers) vs. product solutions (less competitive/more value-add to customers) • Product Solution involves supplying the manufacturing engineering, large-parts, small parts (mechanical and
Slide 10: Strategic Production Solutions for Profitable Growth
Strategic Production Solutions for Profitable Growth NRC approved Nuclear Isotope and Fissile (pending) Transport Casks S250 Proton Beam Cancer Treatment (510k clearance) Carbon Black Furnaces GDEB/BAE: Multiple Confidential Virginia Class Product Assemblies Sapphire Furnaces
Slide 11: FY2013 Customer and Sector Pipeline
FY2013 Customer and Sector Pipeline Alternative Energy: Sapphire Pipeline: $6 - $12M Solar Pipeline: $5 - $8M Nuclear: $7 - $12M Defense and Aerospace: $10 - $14M Medical: $8 - $10M Commercial Industrial: $3 - $6M Current Backlog (July 13 th ) $28.9-million
Slide 12: Served Markets: "Achieving Balance" in FY2013
Served Markets: “Achieving Balance” in FY2013 FY2012: Single Product Dependence and Risk FY2013 Outlook: Balance with Multiple Volume Products
Slide 13: www.TechPrecision.com www.ranor.com www.wcmcsolutions.com
www.TechPrecision.com www.ranor.com www.wcmcsolutions.com